Management of pyoderma gangrenosum - An update

Indian Journal of Dermatology, Venereology and Leprology

Volumn 70, Issue 6, 2004, Pages 329-335

  Bhat, Ramesh ^a  

^a FATHER MULLER MEDICAL COLLEGE   (India)

Author keywords

Corticosteroids; Pyoderma gangrenosum; Therapy

Indexed keywords

ARABINOSIDE; AZATHIOPRINE; BENZOYL PEROXIDE; CHLORAMBUCIL; CLOFAZIMINE; COLCHICINE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; DAUNORUBICIN; DEXAMETHASONE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METHYLPREDNISOLONE; MINOCYCLINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICOTINE; SALAZOSULFAPYRIDINE; SULFAMETHOXYPYRIDAZINE; SULFAPYRIDINE; TACROLIMUS; THALIDOMIDE; TRIPTERYGIUM WILFORDII EXTRACT;

BONE MARROW SUPPRESSION; CHILL; CLINICAL FEATURE; CLINICAL TRIAL; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ENTERITIS; FEVER; GASTROINTESTINAL TOXICITY; HEADACHE; HIRSUTISM; HUMAN; HYPERTENSION; INTESTINE OBSTRUCTION; LEUKOPENIA; LIVER TOXICITY; LYMPHOMA; MUSCLE CRAMP; MYELOPROLIFERATIVE DISORDER; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; PYODERMA GANGRENOSUM; REVIEW; RHEUMATOID ARTHRITIS; SIDE EFFECT; SKIN DISCOLORATION; SPLEEN INFARCTION; SUNBURN; TREMOR;

EID: 14844319357     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Fowler JF, Callen JP. Pyoderma gangrenosum. Dermatol Clin 1983;1:615-23.
2. th Ed. London: Blackwell; 1998. p. 2186-9.
3. Brunsting LA, Goeckerman WH, O'Leary PA. Pyoderma (ecthyma) gangrenosum: Clinical and experimental observations in five cases occurring in adults. Arch Dermatol 1930;22:655-80.
4. Callen JP. Pyoderma gangrenosum and related disorders. Adv Dermatol 1989;4:51-69.
5. Wolff K, Stingl G. Pyoderma gangrenosum. In: Dermatology in general medicine. Freedberg IM, Eisen AZ, Wolff K, Austen FK, Goldsmith LA, Katz SI, et al, editors. New York: McGraw Hill; 1999. p. 1140-8.
6. Powell FC, Schroeter AL, Perry HO, Su WP. Direct immunofluorescence in pyoderma gangrenosum. Br J Dermatol 1983;108:287-93.
7. Sams HH, Mitchell MM, Stratton CW, King LE Jr. Culture and immunohistochemical evidence of chlamydia infection in ulcerative pyoderma gangrenosum. J Am Acad Dermatol 2003;48:966-9.
8. Darie C, Boutalba S, Fichter P, Huret JF, Jaillot P, Deplus F, et al. Aortitis after G-CSF injections. Rev Med Interne 2004;25:225-9.
9. von den Driesch P. Pyoderma gangrenosum: A report of 44 cases with follow up. Br J Dermatol 1997;137:1000-5.
10. Powell FC, Su WP, Perry HO. Pyoderma gangrenosum. Classification and management. J Am Acad Dermatol 1996;34:395-412.
11. Mlika RB, Riahi I, Fenniche S, Mokni M, Dhaoui MR, Dess N, et al. Pyoderma gangrenosum: Report of 21 cases. Int J Dermatol 2002;41:65-8.
12. Graham JA, Hansen KK, Rabinowitz LG, Esterly NB. Pyoderma gangrenosum in infants and children. Pediatr Dermatol 1994;11:10-7.
13. Bhat RM, Shetty SS, Kamath GH. Pyoderma gangrenosum in childhood. Int J Dermatol 2004;43:205-7.
14. Brown TS, Marshall GS, Callen JP. Cavitating pulmonary infiltrate in an adolescent with PG; a rarely recognized extra-cutaneous manifestation of neutrophilic dermatosis. J Am Acad Dermatol 2000;43:108-12.
15. Powell FC, Schroeter AL, Su WP, Perry HO. Pyoderma gangrenosum: A review of 86 patients. Q J Med 1985;55:173-86.
16. O'Loughlin S, Perry HO. A diffuse pustular eruption associated with ulcerative colitis. Arch Dermatol 1978;114:1061-4.
17. Shankar S, Sterling JC, Rybina E. Pustular pyoderma gangrenosum. Clin Exp Dermatol 2003;28:600-3.
18. Ho KK, Otridge B, Vandenberg E, Powell FC. Pyoderma gangrenosum, polycythemia rubra vera and the development of leukemia. J Am Acad Dermatol 1992;27:804-8.
19. Caughman W, Stern R, Haynes H. Neutrophilic dermatosis of myeloproliferative disorders. J Am Acad Dermatol 1983;9:751-8.
20. Wilson-Jones E, Winkelmann RK. Superficial granulomatosis pyoderma: A localized vegetative form of pyoderma gangrenosum. J Am Acad Dermatol 1988;18:511-21.
21. Quinely SR, Gibson LE, Winkelmann RK. Superficial granulomatous pyoderma: Clinicopathologic spectrum. Mayo Clin Proc 1989;64:37-43.
22. Prystowsky JH, Kahn SN, Lazarus GS. Present status of pyoderma gangrenosum. Review of 21 cases. Arch Dermatol 1989;125:57-64.
23. Stolmaan LP, Rosenthal D, Yaworsky R, Horan F. Pyoderma gangrenosum and rheumatoid arthritis. Arch Dermatol 1975;111:1020-3.
24. Powell FC, Schroeter AL, Su WP, Perry HO. Pyoderma gangrenosum and monoclonal gammopathy. Arch Dermatol 1983;119:468-72.
25. Birnkrant MJ, Papadopoulos AJ, Schwartz RA, Lambert WC. Pyoderma gangrenosum, acne conglobata and IgA gammopathy. Int J Dermatol 2003;42:213-6.
26. Miserocchi E, Modoroto G, Foster CS, Brancato R. Ocular and extra-cutaneous involvement in pyoderma gangrenosum. Ophthalmology 2002;109:1941-3.
27. Rose EG, Barnes EA, Uddin JM. Pyoderma gangrenosum of the ocular adnexa: A rare condition with characteristic clinical appearances. Ophthalmology 2003;110:801-5.
28. Paller SA, Sahn EE, Garen PD, Dobson RL, Chadwick EG. Pyoderma gangrenosum in paediatric acquired immunodeficiency syndrome. J Paediatr 1990;117:63-6.
29. Clark HH, Cohen PR. Pyoderma gangrenosum in an HIV infected patient. J Am Acad Dermatol 1995;32:912-4.
30. Sayal SK, Malik AK Banerjee S. Pyoderma gangrenosum in HIV patient. Indian J Dermatol Venereol Leprol 1997;63:58-60.
31. Crowson AN. Martin MC Jr, Magro C. Pyoderma gangrenosum: A review. J Cutan Pathol 2003;30:97-107.
32. Callen JP. Pyoderma gangrenosum. Lancet 1998;351:581-5.
33. Sanders S, Tahan SR, Kwan T, Magro CM. Giant cells in pyoderma gangrenosum. J Cutan Pathol 2001;28:97-100.
34. Chow KP, Ho CV. Treatment of pyoderma gangrenosum. J Am Acad Dermatol 1996;34:1047-60.
35. Talansky AL, Meyers S, Greenstein AJ, Janowitz HD. Does intestinal resection heal pyoderma gangrenosum of inflammatory bowel disease? J Clin Gastroenterol 1983;5:207-10.
36. Powell FC, O'Kane M. Management of pyoderma gangrenosum. Dermatol Clin 2002;20:347-55.
37. Philips TJ, Bigby M, Bercovitch L. Cultured allografts as an adjunct to the medical treatment of problematic leg ulcers. Arch Dermatol 1991;127:799-801.
38. Jennings JL. Pyoderma gangrenosum: Successful treatment with intralesional steroids. J Am Acad Dermatol 1983;9:575-80.
39. Ko CB, Walton S, Wyatt EH. Pyoderma gangrenosum: Associations revisited. Int J Dermatol 1992;31:574-7.
40. Sanders CJ, Hulsmans RF. Successful treatment of pyoderma gangrenosum with topical 5-aminosalicylic acid. Cutis 1993;51:262-4.
41. Nguyen LQ, Weiner J. Treatment of pyoderma gangrenosum with benzoyl peroxide. Cutis 1977;19:842-4.
42. de Cock KM, Thorne MG. The treatment of pyoderma gangrenosum with sodium cromoglycate. Br J Dermatol 1980;102:231-3.
43. Mrowietz U, Christophers E. Clearing of pyoderma gangrenosum by intralesional cyclosporin A. Br J Dermatol 1991;125:499.
44. Tsele E, Yu RC, Chu AC. Pyoderma gangrenosum - response to topical nitrogen mustard. Clin Exp Dermatol 1992;17:437-40.
45. Richter-Hintz D, Schuppe H, Homey B, Lehmann P, Ruzicka T. Topical tacrolimus (FK 506) is effective in the treatment of pyoderma gangrenosum. J Am Acad Dermatol 2000;42:304-5.
46. Shapiro D, Gilat D, Fisher-Feld L, Shemer A, Gold I, Tran H. Pyoderma gangrenosum successfully treated with perilesional Granulocyte macrophage colony stimulating factor. Br J Dermatol 1998;138:368-9.
47. Holt PJ, Davies MG, Saunders KC, Nuki J. Pyoderma gangrenosum: Clinical and laboratory findings in 15 patients with special reference to polyarthritis. Medicine 1980;59:114-33.
48. Perry HO. Pyoderma gangrenosum. Australas J Dermatol 1982;23:53-61.
49. Pasricha JS, Reddy R, Nandakishore TH, Khera VI. Pyoderma gangrenosum treated with dexamethasone pulse therapy. Indian J Dermatol Venereol Leprol 1991;57:225-8.
50. Altman J, Mopper C. Pyoderma gangrenosum treated with sulfone drugs. Minn Med 1966;49:22-6.
51. Zhu YI, Stiller MJ. Dapsone and sulfones in dermatology: Overview and update. J Am Acad Dermatol 2001;45:420-34.
52. Kaplan B, Trau H, Sofer E, Feinstein A, Schewach-Millet M. Treatment of pyoderma gangrenosum with clofazimine. Int J Dermatol 1992;31:591-3.
53. Lynch WS, Bergfeld WF. Pyoderma gangrenosum responsive to minocycline hydrochloride. Cutis 1978;21:535-8.
54. Newell LM, Malkinson FD. Pyoderma gangrenosum: response to cyclophosphamide therapy. Arch Dermatol 1983;119:495-7.
55. Zonana-Nacach A, Jimenz-Balderas FJ, Martinez-Osuna P, Mintz G. Intravenous cyclophosphamide pulses in the treatment of pyoderma gangrenosum associated with rheumatoid arthritis: Report of 2 cases and review of the literature. J Rheumatol 1994:21:1352-6.
56. Elgart G, Stover P, Larson K, Sutter C, Scheibner S, Davis B, et al. Treatment of pyoderma gangrenosum with cyclosporine: Results in seven patients. J Am Acad Dermatol 1991;24:83-6.
57. Fradin MS, Ellis CN, Voorhees JJ. Management of patients and side effects during cyclosporine therapy for cutaneous disorders. J Am Acad Dermatol 1990;23:1265-75.
58. Abu-Elmagd K, Van Theil DH, Jegasothy BV, Jacobs JC, Carroll P, Rodriquez-Rilo H, et al. Resolution of severe pyoderma gangrenosum in a patient with streaking leukocyte factor disease after treatment with tacrolimus (FK 506). Ann Intern Med 1993;119:595-8.
59. Liu V, Mackool BT. Mycophenolate in dermatology. J Dermatol Treat 2003;14:203-11.
60. Frieling V, Luger TA. Mycophenolate mofetil and leflunomide: Promising compounds for treatment of skin diseases. Clin Exp Dermatol 2002;27:562-70.
61. Regueiro M, Valentine J, Plevy S, Fleisher MR, Lichtenstein GR. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease. Am J Gastroenterol 2003;98:1821-6.
62. Li LF. Treatment of pyoderma gangrenosum with oral Tripterygium wilgordii multiglycoside. J Dermatol 2000;27:478-81.
63. Gupta AK, Shear NH, Sauder DN. Efficacy of human intravenous globulin in pyoderma gangrenosum. J Am Acad Dermatol 1995;32:140-2.
64. Rustin MH, Gilkes JJ, Robinson TW. Pyoderma gangrenosum associated with Behçet's disease: Treatment with thalidomide. J Am Acad Dermatol 1990;23:941-4.
65. Kanekura T, Usuki K, Kanzaki T. Nicotine for pyoderma gangrenosum (letter). Lancet 1995;345:1058.
66. Miyachi Y, Niwa Y. Effects of potassium iodide, colchicine and dapsone on the generation of polymorphonuclear leukocyte derived oxygen intermediates. Br J Dermatol 1982;107:209-14.